Additionally, numerous pieces of evidence suggest a significant association between the NLRP3 inflammasome activation in the stress responses and depression's underlying causes, and inhibition of it exerts as a promoting therapeutic target for depressive disorders (11, 12). This evidence concerns the gene NLRP3 and depressive symptom measurement.